GAA
PACB icon

Green Alpha Advisors’s Pacific Biosciences PACB Stock Holding History

Green Alpha Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$79.2K Sell
33,428
-145,227
-81% -$205K 0.05% 105
2026
Q2 		$300K Sell
178,655
-3,963
-2% -$5.76K 0.2% 85
2026
Q1 		$241K Sell
182,618
-848
-0.5% -$1.52K 0.24% 87
2025
Q4 		$343K Buy
183,466
+9,441
+5% +$18.1K 0.31% 85
2025
Q3 		$223K Sell
174,025
-32,998
-16% -$44.7K 0.22% 86
2025
Q2 		$257K Sell
207,023
-9,771
-5% -$11.3K 0.25% 88
2025
Q1 		$256K Buy
216,794
+114,373
+112% +$175K 0.27% 89
2024
Q4 		$187K Buy
102,421
+38,208
+60% +$74.6K 0.15% 129
2024
Q3 		$109K Buy
64,213
+30,117
+88% +$49.5K 0.09% 134
2024
Q2 		$46.7K Sell
34,096
-15,851
-32% -$32K 0.04% 137
2024
Q1 		$187K Buy
49,947
+8,512
+21% +$49.8K 0.14% 132
2023
Q4 		$406K Sell
41,435
-32,811
-44% -$268K 0.29% 118
2023
Q3 		$620K Sell
74,246
-36,865
-33% -$421K 0.48% 77
2023
Q2 		$1.48M Buy
111,111
+6,216
+6% +$75.5K 0.97% 33
2023
Q1 		$1.21M Buy
104,895
+437
+0.4% +$4.34K 0.85% 46
2022
Q4 		$854K Sell
104,458
-312
-0.3% -$2.69K 0.71% 56
2022
Q3 		$608K Sell
104,770
-318,066
-75% -$1.82M 0.52% 87
2022
Q2 		$1.87M Buy
422,836
+387,032
+1,081% +$2.35M 0.43% 55
2022
Q1 		$326K Buy
35,804
+7,757
+28% +$89.3K 0.22% 124
2021
Q4 		$574K Buy
28,047
+2,818
+11% +$68K 0.39% 103
2021
Q3 		$645K Buy
25,229
+4,950
+24% +$147K 0.45% 108
2021
Q2 		$709K Buy
+20,279
New +$590K 0.48% 103

Other funds holding PACB

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return
DWM
DKM Wealth Management Stockton, California $158M AUM 11.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Green Alpha Advisors's PACB Position: Q3 2026 in Review

Green Alpha Advisors reduced its Pacific Biosciences (PACB) stake by 81% in Q3 2026, selling an estimated $205K and leaving 33,428 shares worth $79.2K. The position accounts for 0.05% of the portfolio, ranked #105.

Green Alpha Advisors first reported a position in PACB in Q2 2021 and has held it in 22 quarters since. The position peaked at $1.87M in Q2 2022. 6 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Green Alpha Advisors held 33,428 shares of Pacific Biosciences worth $79.2K as of Q3 2026.
  • Green Alpha Advisors sold 145,227 Pacific Biosciences shares in Q3 2026, an estimated $205K.
  • Pacific Biosciences made up 0.05% of Green Alpha Advisors's portfolio in Q3 2026, its #105 holding.
  • Green Alpha Advisors first reported a position in Pacific Biosciences in Q2 2021 and has held it in 22 quarters since.
  • Green Alpha Advisors's Pacific Biosciences position peaked at $1.87M in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.